author-photo

Mark O'Rourke

Greenville Health System

16

Papers

3153

Citations

Citation Trend

Filter By

Papers (14) Sort By

Journal Conference Others

Phase 2 trial of the indoleamine 2,3-dioxygenase pathway (IDO) inhibitor indoximod plus gemcitabine/nab-paclitaxel for the treatment of metastatic pancreas cancer: Interim analysis.

2016 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (26)
Stepwise development of a cancer care delivery research study to evaluate the prevalence of virus infections in cancer patients

2016 Future Oncology
Show All
- Source
- Cite
- Save
Citations (2)
Circulating Tumor Cells and Response to Chemotherapy in Metastatic Breast Cancer: SWOG S0500

2014 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (412)
Gemcitabine, cisplatin, and sunitinib for metastatic urothelial carcinoma and as preoperative therapy for muscle-invasive bladder cancer

2013 Clinical Genitourinary Cancer
Show All
- Source
- Cite
- Save
Citations (72)
Abstract S5-07: SWOG S0500 – A randomized phase III trial to test the strategy of changing therapy versus maintaining therapy for metastatic breast cancer patients who have elevated circulating tumor cell (CTC) levels at first follow-up assessment

2013 Cancer Research
Show All
- Source
- Cite
- Save
Citations (14)
Phase III Trial of Cetuximab, Bevacizumab, and 5-Fluorouracil/Leucovorin vs. FOLFOX- Bevacizumab in Colorectal Cancer

2012 Clinical Colorectal Cancer
Show All
- Source
- Cite
- Save
Citations (55)
Randomized Phase III Trial of Gemcitabine-Based Chemotherapy With In Situ RRM1 and ERCC1 Protein Levels for Response Prediction in Non–Small-Cell Lung Cancer

2009 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (157)
Results of a phase II study of weekly paclitaxel plus carboplatin in advanced carcinoma of unknown primary origin : A reasonable regimen for the community-based clinic?

2007 Cancer Investigation
Show All
- Source
- Cite
- Save
Citations (11)
A multicenter phase II study of a five-day regimen of oral 5-fluorouracil plus eniluracil with or without leucovorin in patients with metastatic colorectal cancer

2000 Annals of Oncology
Show All
- Source
- Cite
- Save
Citations (25)
Multicenter Phase II Study to Evaluate a 28-Day Regimen of Oral Fluorouracil Plus Eniluracil in the Treatment of Patients With Previously Untreated Metastatic Colorectal Cancer

2000 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (40)